These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6161671

  • 21. Estimation of glomerular filtration rate by serum creatinine and serum beta 2-microglobulin.
    Trollfors B, Norrby R.
    Nephron; 1981; 28(4):196-9. PubMed ID: 6170902
    [Abstract] [Full Text] [Related]

  • 22. Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.
    Werner K, Pihlsgård M, Elmståhl S, Legrand H, Nyman U, Christensson A.
    Nephron; 2017; 137(1):29-37. PubMed ID: 28407629
    [Abstract] [Full Text] [Related]

  • 23. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
    Teruel-Briones JL, Fernández-Lucas M, Rivera-Gorrin M, Ruiz-Roso G, Díaz-Domínguez M, Rodríguez-Mendiola N, Quereda-Rodríguez-Navarro C.
    Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
    [Abstract] [Full Text] [Related]

  • 24. Amniotic fluid beta-2-microglobulin in normal and complicated pregnancies. Correlation with gestational age, creatinine concentration and L/S ratio.
    Puolakka J, Ylöstalo P, Tuimala R, Haapalahti J, Järvinen PA.
    Gynecol Obstet Invest; 1982; 13(3):129-34. PubMed ID: 6178654
    [Abstract] [Full Text] [Related]

  • 25. Creatinine clearance, cystatin C, beta2-microglobulin and TATI as markers of renal function in patients with proteinuria.
    Tramonti G, Cipollini I, Annichiarico C, Lorusso P, Panicucci E, Mariani G, Barsotti G.
    J Nephrol; 2012; 25(6):976-82. PubMed ID: 22307441
    [Abstract] [Full Text] [Related]

  • 26. [Usefulness of serum cystatin-C as a marker of the renal function: a comparative evaluation with beta 2-microglobulin, alpha 1-microglobulin and creatinine].
    Hotta O, Yusa N, Mukaiyama I, Taguma Y.
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):797-803. PubMed ID: 10655728
    [Abstract] [Full Text] [Related]

  • 27. Diabetic hypouricemia as an indicator of clinical nephropathy.
    Shichiri M, Iwamoto H, Marumo F.
    Am J Nephrol; 1990 Dec; 10(2):115-22. PubMed ID: 2190467
    [Abstract] [Full Text] [Related]

  • 28. Plasma levels of beta 2-microglobulin in rheumatoid arthritis.
    Sjöblom KG, Saxne T, Wollheim FA.
    Ann Rheum Dis; 1980 Aug; 39(4):333-9. PubMed ID: 6159827
    [Abstract] [Full Text] [Related]

  • 29. Urine B2-microglobulin in patients with macroglobulinemia Waldenström.
    Engström W, Wahrgren P.
    Clin Chim Acta; 1980 Jul 17; 105(1):123-6. PubMed ID: 6156780
    [Abstract] [Full Text] [Related]

  • 30. [Beta 2 microglobulin. Index of glomerular filtration in children].
    Leroy D, Mauriat F, Dechaux M, Chopin N, Broyer M, Sachs C.
    Arch Fr Pediatr; 1984 Jan 17; 41(1):43-7. PubMed ID: 6372730
    [Abstract] [Full Text] [Related]

  • 31. Rationale and application of beta-2-microglobulin measurements to detect acute transplant rejection.
    Roxe DM, Siddiqui F, Santhanam S, del Greco F, Wolf J.
    Nephron; 1981 Jan 17; 27(4-5):260-4. PubMed ID: 6167873
    [Abstract] [Full Text] [Related]

  • 32. Plasma beta 2 microglobulin turnover in renal insufficiency.
    Vincent C, Pozet N, Revillard JP.
    Acta Clin Belg; 1980 Jan 17; 35 Suppl 10():2-13. PubMed ID: 6157287
    [No Abstract] [Full Text] [Related]

  • 33. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
    Kontessis PS, Jones SL, Barrow SE, Stratton PD, Alessandrini P, De Cosmo S, Ritter JM, Viberti GC.
    J Lab Clin Med; 1993 Mar 17; 121(3):415-23. PubMed ID: 8445289
    [Abstract] [Full Text] [Related]

  • 34. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG, Grubb AO, Nilsson JA, Norrgren K, Sterner G, Sundkvist G.
    J Intern Med; 2004 Dec 17; 256(6):510-8. PubMed ID: 15554952
    [Abstract] [Full Text] [Related]

  • 35. Beta 2-microglobulin determined by radioimmunoassay with monoclonal antibody.
    Swanson RA, Tracy RP, Katzmann JA, Wilson DM, Young DS.
    Clin Chem; 1982 Oct 17; 28(10):2033-9. PubMed ID: 6181908
    [Abstract] [Full Text] [Related]

  • 36. Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose.
    Daugaard G, Rossing N, Rørth M.
    Cancer Chemother Pharmacol; 1988 Oct 17; 21(2):163-7. PubMed ID: 3280153
    [Abstract] [Full Text] [Related]

  • 37. Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group.
    Staessen JA, Lauwerys RR, Buchet JP, Bulpitt CJ, Rondia D, Vanrenterghem Y, Amery A.
    N Engl J Med; 1992 Jul 16; 327(3):151-6. PubMed ID: 1608406
    [Abstract] [Full Text] [Related]

  • 38. The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate.
    Simonsen O, Grubb A, Thysell H.
    Scand J Clin Lab Invest; 1985 Apr 16; 45(2):97-101. PubMed ID: 3923607
    [Abstract] [Full Text] [Related]

  • 39. Serum beta-2-microglobulin levels in urological cancer.
    Bunning RA, Haworth SL, Cooper EH.
    J Urol; 1979 May 16; 121(5):624-5. PubMed ID: 86616
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.